ILC Dover Defines the Future of Sterile Manufacturing with the soloPURE(TM) Flexible Aseptic Isolator
AsiaNet 88970
NEWARK, Del., April 13, 2021 /PRNewswire=KYODO JBN/ --
ILC Dover LP ("ILC Dover" or the "Company"), specializing in the innovative
design and production of single-use flexible solutions for global
pharmaceutical and biopharmaceutical processing, today introduced the
soloPURE(TM) flexible aseptic isolator, a cost-effective, closed-barrier system
for sterile manufacturing. With a fully disposable, single-use chamber and a
CAPEX-efficient compact design, soloPURE(TM) represents the future of sterile
manufacturing.
Photo - https://mma.prnewswire.com/media/1485718/ILC_Dover_LP_soloPURE.jpg
soloPURE(TM) provides a closed, Grade-A, aseptic environment for fill finish
activities requiring positive and negative pressures, giving organizations with
facility restraints or expensive closed-barrier systems a better way to handle
sterile potent powders, including products previously thought to be "out of
reach" in conventional barrier systems. This economical flexible isolator
delivers performance equivalent to full hard-walled aseptic isolation systems
through bolt-on modules for lyophilization that deliver more capabilities
without the added expense. Beyond cost savings, soloPURE(TM) maximizes
productivity with a fully disposable chamber, maximizes cleanroom efficiency
through a smaller footprint, enhances operator access with double-sided entry,
and mitigates risk with integrity testing throughout its lifecycle.
"ILC Dover is proud to introduce soloPURE(TM) to the biopharmaceutical market
and provide significant time and cost savings to processors through effective
single-use solutions," said David Radspinner, President of PharmBio at ILC
Dover. "soloPURE(TM) combines Solo Containment's rich history in single-use
isolators and ILC Dover's expertise in flexible powder handling solutions to
deliver an efficient, economical, and safe isolator that drastically improves
workflow and output for sterile manufacturing."
"soloPURE(TM) demonstrates both the processing power and sensibility behind
single-use solutions, especially for sterile or aseptic processes," said Martyn
Ryder, Business and Product Development Manager at ILC Dover. "The single-use,
disposable chamber alone allows for rapid campaign changeover, while its
double-sided entry increases productivity. While single-use solutions have
eluded aseptic processes for decades, soloPURE(TM) is here to represent the
future of sterile manufacturing."
soloPURE(TM) is available with the capability to sterilize in-place with VHP or
operate with a single-use, disposable gamma-irradiated chamber. It can be
ordered as a turnkey solution with fast delivery. The launch of soloPURE(TM)
supplements ILC Dover's growing portfolio of single-use solutions for sterile
processes and powder transport and hydration, including EZ BioPac(R),
DoverPac(R), and ArmorFlex(R) Films.
SOURCE: ILC Dover, Inc.
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。